Company profile for GH Research

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases. In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy...
GH Research is a privately-held clinical-stage biopharmaceutical company, founded in 2018, developing novel therapies for the management of mental diseases. In order to obtain approval for our therapies, we are investigating their safety and efficacy in clinical trials as required by the United States Food and Drug Administration, European Medicines Agency, and other regulatory agencies worldwide.GH001 has completed a healthy volunteer study and is currently being investigated in patients with Treatment-Resistant Depression. We believe our lead product GH001 has the potential to offer ultra-rapid and deep remissions in depression.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Ireland
Address
Address
28 Baggot Street Lower, Dublin 2
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/09/3164013/0/en/GH-Research-Announces-Novel-Therapies-Symposium-Presentation-and-Posters-at-the-2025-ECNP-Congress.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/08/07/3129095/0/en/GH-Research-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/07/23/3120164/0/en/GH-Research-Announces-Global-Pivotal-Program-Plans-and-Further-Development-Updates.html

GLOBENEWSWIRE
23 Jul 2025

https://www.globenewswire.com/news-release/2025/06/20/3102880/0/en/GH-Research-Submits-Complete-IND-Hold-Response-to-FDA-Ahead-of-Schedule.html

GLOBENEWSWIRE
20 Jun 2025

https://www.globenewswire.com/news-release/2025/05/15/3081974/0/en/GH-Research-Announces-Acceptance-of-Pharmaceutical-Pipeline-Presentation-and-Late-Breaking-Posters-at-the-American-Society-of-Clinical-Psychopharmacology-2025-Annual-Meeting.html

GLOBENEWSWIRE
15 May 2025

https://www.globenewswire.com/news-release/2025/05/08/3077077/0/en/GH-Research-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

GLOBENEWSWIRE
08 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty